Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer.
暂无分享,去创建一个
C. Tournigand | D. Sargent | R. Goldberg | M. Rothenberg | A. de Gramont | T. André | I. Tabah-Fisch | H. Bleiberg | E. Green
[1] S. Cha,et al. 5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study. , 2005, Clinical colorectal cancer.
[2] T. Hickish,et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.
[3] Daniel J Sargent,et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J. Berlin,et al. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] H. Schmoll. The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions. , 2002, Seminars in oncology.
[6] R. Labianca,et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. , 2001, The New England journal of medicine.
[7] C. Wilson,et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] C. Coltman,et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.
[9] D. Serraino,et al. Entry and evaluation of elderly patients in european organization for research and treatment of cancer (EORTC) new‐drug–development studies , 1995, Cancer.
[10] E. Trimble,et al. Representation of older patients in cancer treatment trials , 1994 .
[11] J. Samet,et al. Determinants of cancer therapy in elderly patients , 1993 .
[12] D. Cox. Regression Models and Life-Tables , 1972 .
[13] R. L. Plackett,et al. The Analysis of Variance , 1960 .